US Patent Issued to NANJING ANJI BIOLOGICAL TECHNOLOGY on April 29 for "Recombinant fused polypeptide and use thereof" (Chinese Inventor)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,286,461, issued on April 29, was assigned to NANJING ANJI BIOLOGICAL TECHNOLOGY Co. LTD. (Nanjing, China).

"Recombinant fused polypeptide and use thereof" was invented by Hanmei Xu (Nanjing, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention discloses a recombinant fused polypeptide, a preparation method therefor, and use thereof. The recombinant fused polypeptide is represented by the following general formula: X-linker1-Y; Y-linker1-X; X-linker2-Y; Y-linker2-X, where X is PRCWRGEGGGGIVRRADRAAVPGGGGRGD; and Y is Acetyl-SDKPGGGGTSLDASIIWAMMQNGGGGLSKL. The recombinant fused polypeptide according to the present invention can treat v...